Option Care Health, Inc. (OPCH) Stock Analysis
Recovery setup
Healthcare · Medical Care Facilities
Sell if holding. Multiple concerning factors at $21.11: Concentration risk — Supplier: top-4 pharmaceutical vendors (68.0%); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1).
Option Care Health is the largest independent provider of home and alternate site infusion services, operating 196 locations in 43 states with a multidisciplinary team of over 5,000 clinicians. Revenue is generated through reimbursement from managed care organizations (88% of... Read more
Sell if holding. Multiple concerning factors at $21.11: Concentration risk — Supplier: top-4 pharmaceutical vendors (68.0%); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1). Chart setup: Death cross but MACD improving, RSI 52. Score 5.2/10, moderate confidence.
Passes 7/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 50d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
Recent developments
updated 2026-06-09Recent Developments — Option Care Health, Inc.
Latest news
- NEWS A Look at Option Care Health Inc (OPCH) After 3.2% Decline -- GF Value $42.53 vs Price $26.87 - GuruFocus — GuruFocus negative
- NEWS Option Care Health (OPCH) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance — Yahoo Finance neutral
- NEWS Why Option Care Health Stock Is Sliding Today - TipRanks — TipRanks negative
- NEWS Option Care Health (OPCH) To Report Earnings Tomorrow: Here Is What To Expect - StockStory — StockStory neutral
- NEWS Option Care Health (OPCH) To Report Earnings Tomorrow: Here Is What To Expect - TradingView — TradingView neutral
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHSuppliertop-4 pharmaceutical vendors68%10-K Item 1: 'approximately 68% of the Company’s pharmaceutical and medical supply purchases were from four vendors.'
- LOWCustomerlargest payer14%10-K Item 1: 'The Company’s largest payer represented approximately 14% of its revenue for the year ended December 31, 2025.'
Material Events(8-K, last 90d)
- 2026-05-05Item 5.02LOWChristopher Grashoff (Chief Growth Officer) departing effective May 8, 2026. Entitled to separation benefits per Executive Severance Plan. No successor named for the role.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Analyst Consensus
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Multiple concerning factors at $21.11: Concentration risk — Supplier: top-4 pharmaceutical vendors (68.0%); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1). Chart setup: Death cross but MACD improving, RSI 52. Prior stop was $19.63. Score 5.2/10, moderate confidence.
Take-profit target: $25.39 (+20.3% upside). Prior stop was $19.63. Stop-loss: $19.63.
Concentration risk — Supplier: top-4 pharmaceutical vendors (68.0%); V7 low-quality RISK_OFF penalty: -0.5 (Q=4.1); Earnings estimates trending DOWN.
Option Care Health, Inc. trades at a P/E of 15.7 (forward 9.8). TrendMatrix value score: 7.7/10. Verdict: Sell.
18 analysts cover OPCH with a consensus score of 4.2/5. Average price target: $29.
What does Option Care Health, Inc. do?Option Care Health is the largest independent provider of home and alternate site infusion services, operating 196...
Option Care Health is the largest independent provider of home and alternate site infusion services, operating 196 locations in 43 states with a multidisciplinary team of over 5,000 clinicians. Revenue is generated through reimbursement from managed care organizations (88% of revenue) and direct government programs (12%), with the largest payer representing approximately 14% of 2025 revenue.